Researchers at Oxford announced today that a nasal spray version of the COVID-19 vaccine they’ve developed with AstraZeneca failed in early stages of clinical trials.

The drive to develop a nasal spray against COVID-19 infection suffered a setback Tuesday after AstraZeneca and Oxford University said a trial produced disappointing results.

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts ...

Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against various respiratory infections, including COVID-19, influenza ...

Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal ...

A nasal spray version of AstraZeneca (AZN) and Oxford University's COVID-19 vaccine did not show the desired results in an early trial, according to the journal The Lancet,In the phase ...

AstraZeneca's COVID-19 nasal spray candidate has come up short in an early-stage trial, failing to produce a strong immune response.

Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans ...

This results in less SARS-CoV-2 attachment and infection. Scientists now think this technology could be adapted to a nasal spray to prevent SARS-CoV-2 infection. How could we stop the virus ...

Vaccines and take-home medicines have helped tackle COVID-19 infections. Now researchers are looking at the potential for nasal sprays to stop the virus replicating in the nose, or to make the ...